PHYSIOMICS PLC Logo

PHYSIOMICS PLC

De-risks oncology drug development for pharma/biotech using modeling and simulation.

PYC | IL

Overview

Corporate Details

ISIN(s):
GB00BDR6W943
LEI:
213800A71DSZ6ABMTQ91
Country:
United Kingdom
Address:
BEE HOUSE, OX14 4SB ABINGDON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Physiomics PLC is a data-driven consultancy that accelerates and de-risks drug development for pharmaceutical and biotech companies. The company provides Model-Informed Drug Development (MIDD) services by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. Specializing in quantitative pharmacology (PK/PD, QSP) and computational biology, Physiomics enables clients to make smarter decisions from pre-clinical discovery through to clinical trials. With a strong focus on oncology, the company utilizes mathematical models and its Virtual Tumour™ technology to predict the effects of novel treatments, providing a more quantitative and translational understanding of new molecules.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-18 16:55
Post-Annual General Meeting Information
Result of AGM
English 25.0 KB
2025-10-17 08:00
Pre-Annual General Meeting Information
Notice of AGM
English 9.4 KB
2025-09-29 08:00
Annual Report
Annual Financial Report
English 604.1 KB
2025-09-22 08:00
Report Publication Announcement
Notice of Results and Investor Presentation
English 11.4 KB
2025-08-06 08:00
Regulatory News Service
Follow-on Contract with UK Biotech Client
English 9.5 KB
2025-07-16 08:00
Regulatory News Service
Contract Award
English 9.5 KB
2025-07-14 08:00
Earnings Release
Trading Update
English 12.0 KB
2025-07-10 08:00
Regulatory News Service
Platform Implementation and Partnership Expansion
English 17.6 KB
2025-05-29 08:00
Regulatory News Service
Physiomics Awarded Contract Extension
English 9.6 KB
2025-03-17 08:00
Regulatory News Service
Contract Award with new client
English 8.8 KB
2025-03-13 08:00
Report Publication Announcement
IMC Presentation on Company Website
English 8.3 KB
2025-03-06 08:00
Earnings Release
Interim Results
English 165.4 KB
2025-02-28 08:00
Report Publication Announcement
Notice of Results and Investor Presentation
English 10.0 KB
2025-02-20 13:00
Major Shareholding Notification
Holding(s) in Company
English 52.0 KB
2025-02-17 14:00
Share Issue/Capital Change
Result of WRAP Retail Offer
English 14.5 KB

Automate Your Workflow. Get a real-time feed of all PHYSIOMICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PHYSIOMICS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PHYSIOMICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland
FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden
FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark
FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom
FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom
FUM
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom
GENI
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France
GV
Genxone Spolka Akcyjna Logo
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland
GX1
Hamlet BioPharma AB Logo
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden
HAMLET
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland
HPE

Talk to a Data Expert

Have a question? We'll get back to you promptly.